Me. Schmidt et al., REGIONAL BRAIN GLUCOSE-METABOLISM AFTER ACUTE ALPHA(2)-BLOCKADE BY IDAZOXAN, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 684-695
Background: Several classes of antidepressant drugs act on alpha(2)-ad
renergic receptors. Studies of patients with disorders responsive to t
reatment with these drugs report group differences in ex vivo measures
of alpha(2)-binding and in vivo responses mediated by alpha(2)-recept
ors. Measurement of regional brain metabolic response to an alpha(2)-a
ntagonist may be a useful method for further definition of the role al
pha(2)-receptor regulation plays in the treatment of neuropsychiatric
disorders. Methods: Regional brain glucose metabolism was measured bef
ore and after infusion with 200 mu g/kg idazoxan with use of F-18-fluo
ro-2-deoxyglucose positron emission tomography in 13 healthy men. Arte
rial drug concentration, behavioral responses, and cardiovascular resp
onses were also measured. Results: The absolute and normalized glucose
metabolic rate significantly increased in primary visual cortex. Sign
ificant increases and decreases occurred in normalized metabolic rates
in prefrontal cortical regions. Measurement of metabolic effects occu
rred during the peak cardiovascular response. Conclusions: Our finding
s are consistent with regionally specific effects of alpha(2)-blockade
. This method may be useful for the study of alpha(2)-receptor functio
n in humans.